Abstract
Purpose
Our review of acute brain insult articles indicated that the patients’ individual (i) timeline panels with the defined time points since the emergency call and (ii) serial brain CT/MRI slice panels through the neurointensive care until death or final brain tissue outcome at 12 months or later are not presented.
Methods
We retrospectively constructed such panels for the 45 aneurysmal subarachnoid hemorrhage (aSAH) patients with a secondary decompressive craniectomy (DC) after the acute admission to neurointensive care at Kuopio University Hospital (KUH) from a defined population from 2005 to 2018. The patients were indicated by numbers (1.–45.) in the pseudonymized panels, tables, results, and discussion. The timelines contained up to ten defined time points on a logarithmic time axis until death (\(n=25\); 56%) or 3 years (\(n=20\); 44%). The brain CT/MRI panels contained a representative slice from the following time points: SAH diagnosis, after aneurysm closure, after DC, at about 12 months (20 survivors).
Results
The timelines indicated re-bleeds and allowed to compare the times elapsed between any two time points, in terms of workflow swiftness. The serial CT/MRI slices illustrated the presence and course of intracerebral hemorrhage (ICH), perihematomal edema, intraventricular hemorrhage (IVH), hydrocephalus, delayed brain injury, and, in the 20 (44%) survivors, the brain tissue outcome.
Conclusions
The pseudonymized timeline panels and serial brain imaging panels, indicating the patients by numbers, allowed the presentation and comparison of individual clinical courses. An obvious application would be the quality control in acute or elective medicine for timely and equal access to clinical care.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Aneurysmal subarachnoid hemorrhage (aSAH), in most cases from a saccular intracranial aneurysm (sIA), is a complex and potentially critical systemic acute condition [83], requiring emergency medical service (EMS) care, immediate CT diagnosis, and transfer to the neurointensive care [5, 17, 22, 59, 97, 98, 104, 110, 112]. In aSAH, brain injuries may be caused by intracerebral hemorrhage (ICH) [15, 108], intraventricular hemorrhage (IVH) [7, 14], acute brain ischemia [53], acute hydrocephalus [49], increased intracranial pressure (ICP) [82, 114], herniations, spreading depolarization [19, 79], seizures [13], perihematomal edema [76], delayed brain injury [20, 64, 79], electrolyte disturbances, cardiopulmonary complications, central nervous system (CNS) or systemic infections, and complications of management.
Clinical articles on aSAH—and on other acute brain insults, including brain infarction, spontaneous ICH or IVH, and traumatic brain injury (TBI)—portray brain injuries and brain outcomes with words, phrases, numbers, scales, scores, risk ratios, areas under curves, tables and graphs, etc. We have difficulty in finding articles with all patients’ individual (i) timeline panels and (ii) serial CT/MRI panels (brain outcome) from the ictus until one to three years: including recanalization in brain infarction; decompressive craniectomy (DC) in brain infarction, TBI, or aSAH; evacuation of ICH or IVH; “vasospasm” and delayed brain injury in aSAH. “Time is Brain” corresponds to “Time is Muscle” in acute coronary care [87]. In the quality control of acute brain infarct care, the term workflow metrics is used and the key time points and periods to the final recanalization are defined and recorded [29, 58, 92]. Actually, any area of Personalized Medicine would necessitate that the patient’s individual timelines are (i) monitored and recorded for the timely conduct of clinical care and (ii) compared to each other for the equal access to clinical services.
In this pilot study, we used DC as an indicator of escalating intracranial conditions since the aSAH ictus in the EMS and neurointensive care. We identified 45 DC patients admitted within 24 h from the CT diagnosis to the Kuopio University Hospital (KUH) Neurointensive Care Unit from 2005 to 2018. We compiled the individual (i) timeline panels (minute scale) since the EMS call and (ii) serial CT/MRI slice panels for the 25 deceased and for the 20 survivors.
Our aims were to illustrate in real life for the clinician readers to evaluate.
-
(a)
the swiftness since the EMS call (112) and possible outliers during the EMS and KUH neurointensive care until the sIA occlusion,
-
(b)
the sites and sizes of aneurysmal ICHs (aICHs) and aneurysmal IVHs (aIVHs),
-
(c)
the development of brain edema, perihematomal edema, and ischemic brain injuries, and.
-
(d)
the extent of brain injuries and brain atrophy at about 12 months after aSAH (brain tissue outcome) in the 20 survivors.
Methods and materials
KUH and EMS in Eastern Finland
KUH, one of the five university hospitals in Finland, is an academic, non-profit, publicly funded tertiary center, which serves a defined population (805,133 in 2018) in Eastern Finland (Fig. 1). The overall KUH catchment area, during the study period 2005–2018, contained four Central Hospitals with the districts of their own, each with 24/7 neuroacutology, CT services, intensive care, and neurorehabilitation (Figs. 1 and 2). The road transfer distances between KUH and each Central Hospital range from 141 to 162 km.
The Finnish Emergency Response Center handles the calls to the public emergency number 112, including requests for EMS [8, 72]. In case of an EMS call, the dispatcher uses a computer-aided and criteria-based dispatch system to classify the mission to one of four urgency classes and to 46 EMS-specific mission types, based on symptoms, findings, or injury mechanisms.
During the study period, the KUH catchment area (Fig. 1) was served by 74 (1 per 10,900 citizens) advanced level and basic level EMS units and one physician-manned helicopter emergency medical service (HEMS) unit. Dispatching and mission control is Global Positioning System (GPS) based.
Role of EMS and HEMS in possible acute brain catastrophe in Eastern Finland
The EMS patient care report contained the following time points in minute scale: 112 call, start of mission, arrival in scene, start of transport to hospital, and at hospital. The ambulance personnel assessed the patient’s condition (including Glasgow Coma Scale (GCS)) and preceding course, previous history, and medications. The EMS physician on duty was contacted by phone, and the ambulance personnel were directed to the first hospital with on-line CT. In case of seizure, i.v. benzodiazepine was immediately administered by the protocol. In case of decreased consciousness on arrival to scene or deterioration during transfer, possibly with a dilated pupil, the treatment was guided by the EMS physician. Supraglottic devices could be used to secure the airways. Rapid sequence intubation was performed either EMS physician on scene or in the first hospital.
KUH NeuroCenter and subarachnoid hemorrhage (SAH) in Eastern Finland
At KUH Neurosurgery, at least two neurosurgeons were on duty at all times, with on-line phone and teleconsultation of digital imaging from the referring hospitals. In principle, all patients with SAH are acutely transferred to KUH for neurointensive care, 4-vessel catheter angiography and/or CT angiography, and neurosurgical and endovascular interventions, virtually regardless of the age or condition on admission, including Hunt & Hess scale (H&H) 4–5 patients [5, 52]. Depending on the patient’s condition and CT findings, intubation (if not performed) and a physician, anesthesiologist, or intensivist attending the patient during the transfer were agreed. Pre-arrival information by HEMS or EMS was given the KUH Emergency area staff.
At KUH, a dedicated team of neurointensivists, neurosurgeons, and interventional neuroradiologists coordinated the aSAH treatment. The KUH Neurovascular Group provided microsurgical or endovascular occlusion of the aneurysm and evacuated significant ICHs with immediate microsurgery. The KUH aSAH protocol in 2005–2018 followed international recommendations, aimed to prevent further brain damage due to re-bleeding, increased ICP (ICP below 20 mmHg; cerebral perfusion pressure at 60–70 mmHg), hydrocephalus, electrolyte disturbances, seizures, cardiac and pulmonary dysfunction, fever, hyperglycemia, and development of delayed brain ischemia. The protocol included extraventricular drainage (EVD), ventricular or parenchymal ICP monitoring, endovascular procedures and intra-arterial nimodipine infusion, and DC. KUH neurointensive care monitoring data is stored in the prospective Finnish Intensive Care Consortium database [78].
Kuopio intracranial aneurysm patient and family database
The database, prospective since 1995, contains all cases of unruptured and ruptured intracranial aneurysms (IAs) admitted to KUH since 1980. A dedicated, full-time nurse administrates the database, interviews all new IA patients, including their family history, and arranges the follow-ups. The clinical data including prescribed medicines, hospital diagnosis, and causes of death have been derived from national registries, using the Finnish personal codes. We have characterized the aSAH patients, e.g., for 14-day mortality and organ donation [52], three-year outcome [5], shunt-dependent hydrocephalus [1] and shunt revisions [100], depression [39], epilepsy [38], pain [56], psychosis [69], secondary hypertension [47], pre-eclampsia [48], and polycystic kidney disease [66, 67]. The collaboration with UMC Utrecht Neurology and the International Stroke Genetics Consortium is significant.
Basic study population of the 788 aSAH patients with ruptured anterior circulation sIA
A total of 788 consecutive aSAH patients with a ruptured anterior circulation sIA were acutely admitted, within 24 h from the CT diagnosis of the first SAH, from the defined Eastern Finnish catchment population to the KUH Neurointensive Care Unit from 2005 to 2018 (Figs. 1 and 2). Their clinical lifelines were re-constructed from their clinical data in the Kuopio database and from the national clinical registries until death (\(n=210\)) or until three years. Their basic variables are in the flowchart (Fig. 2). The cumulative survival rates for the 788 patients at 14 days, 12 months, and 3 years according to the H&H scales (Fig. 2) are in Fig. 3.
Pilot study population of the 45 DC patients
We chose DC as an indicator of severely escalating intracranial conditions since the aSAH ictus during EMS and neurointensive care. Of the 788 aSAH patients, a total of 45 (6%) underwent a secondary DC, while no primary DCs were performed (Fig. 2, Table 1). The decision of DC was agreed case-by-case between the attending neurointensivists and neurosurgeons, during office hours and duty hours. During the same 14 years (2005–2018), we performed 61 DCs for brain infarction [33] and 56 for TBI [37] in Eastern Finland (population 805,133 in 2018) (Fig. 1).
The distribution (IQR; 25–50-75%) of the ICP in each of the 45 patients was analyzed 12 h before and 12 h after the DC (Table 1). A novel, semi-automated image analysis software was used to estimate the area (cm2) of the removed skull (Disior Ltd, Helsinki, Finland).
Individual EMS care and KUH neurointensive care timeline panels for the 45 DC patients
We collected from all available sources (EMS charts; CT, MRI, angiography; intensive care; interventions; hospital case reports) the defined time points (Fig. 4) to reconstruct the clinical timelines for each of the 45 DC patients. The 25 deceased DC patients are numbered 1.–25. (Figs. 4A and 5A) and the 20 surviving DC patients 26.–45. (Figs. 4B and 5B). The timelines allowed to calculate and compare the times passed between any two time points, e.g., from the ambulance arrival to the first CT (minutes), the KUH arrival (minutes), and the sIA occlusion (hours) (Fig. 4, Table 2). The time periods that seemed outliers (very short or very long) were re-checked. Table 3 presents four essential time points according to the weekday, the office hours, and the duty hours.
Possible re-bleeds until the sIA occlusion among the 45 DC patients
The patients’ timelines were analyzed for possible re-bleeds until the sIA occlusion (Figs. 4 and 5, Tables 1 and 4). The verified re-bleeds were seen in two consecutive CT scans, and the suspected re-bleeds were considered as worsening of the clinical condition (seizure, unconsciousness, dilated pupil). The CT-verified re-bleeds during or after the sIA occlusion were also registered.
Individual serial CT/MRI scan panels for the 45 DC patients
The KUH digital image archive (PACS) is linked to the four Central Hospitals in Eastern Finland (Figs. 1 and 2). We were able to review and retrieve all CT scans, MRI scans, and angiographies in the five digital archives of the 45 DC patients, using their personal identity codes. For each DC patient, we chose three representative slices (before and after the sIA occlusion and after DC), and for the 20 survivors, the fourth slice at about 12 months (Fig. 5). We recorded the date and the clock time of the brain imaging study in which our experienced neuroradiologists saw the first signs suggestive of brain ischemia.
Literature search for published individual timeline panels or serial CT/MRI panels for all patients in acute brain catastrophe cohorts
We searched PubMed for English articles from 2000 to 2022 on human brain insult cohorts (brain infarction, ICH, IVH, SAH, and TBI) with (i) all patients’ individual timeline illustration panels since the ictus through EMS care, neurointensive care, and rehabilitation, to the outcome at one to three years (Table 5). As of 6/2022, the 218 hits contained only one (our own) article with a timeline panel [100]. Instead, four known articles with the timeline panels [48, 50, 51, 99] were not found because “timeline” and “lifeline” were missing in the abstracts. We also searched for articles on (ii) all patients’ individual serial CT/MRI image panels since the ictus until one to three years, disclosing final brain injury areas and atrophy (Table 6). Our search words are presented in Tables 5 and 6. Thesaurus (thesaurus.com) was reviewed for synonyms for the search words.
Statistical methods
The categorical variables were expressed in proportions, and the χ2 test was used for comparisons. The continuous variables were expressed in medians, quartiles, and ranges, and the Mann–Whitney \(U\) test was used for comparisons. The time periods between two defined time points were expressed in minutes, hours, days, or months. Their distributions were presented with five times, as follows: shortest–25% quartile–median–75% quartile–longest (Tables 1 and 2). The Kaplan–Meier analysis was used to calculate the cumulative mortality rates. In the 45 DC patients (25 dead and 20 survivors), univariate analysis was used to identify factors that associated with the death. Factors associated with a favorable outcome (modified Rankin Scale (mRS) 0–2) and return to work were also searched. P values < 0.05 were considered significant. We used the SPSS 27 statistical software (SPSS, Inc., Chicago, IL).
Ethical aspects
The KUH Research Ethics Committee approved the study. The KUH Neurosurgery IA Study Group had received a written informed consent from all patients in the database. The Ministry of Social Affairs and Health of Finland approved the data fusion from the national registries. The patients of the study cohort were not contacted during the study. In this article, we present pseudonymized data only on the 45 DC patients. We excluded from the timelines, CT/MRI slice panels, tables, and texts the following data: name; gender; date, month, and year of aSAH; clock times; time period lengths (except the time to death in Fig. 5A). The Kuopio IA Database does not contain face photos. The CT and MRI slices, three or four per patient (Fig. 5), do not allow individual face recognition. Overall, the data presented does not yield the correct attribution to an individual patient (name, personal identity code, face photo or video) without the additional information strictly kept by us within the KUH Information System.
Results
45 DC patients vs. 743 no-DC patients
The 45 DC patients were younger (median age 47 years; \(P <0.05\)) and more often males (58%; \(P\) 0.03) than the 743 (94%) no-DC patients (Fig. 2). Of the 45 DC patients, 25 (56%) died (patients 1.–25.) and 20 (44%) were alive (patients 26.–45.) at three years (Fig. 3). Figure 5 presents the serial CT or MRI slices for each of them, according to the H&H grades (3–5) on admission, as well as the mRS at 3 years for the 20 survivors. The MCA bifurcation sIA ruptured in 24 (53%) DC patients, in all but one causing an aICH (\(n=23/24\); 96%) (Figs. 2 and 5, Table 1). In the 357 (45%) H&H 3 to 5 patients with no DC (Fig. 2), 124 MCA bifurcation sIAs (35%) had ruptured, almost equally with aICH (\(n=97/124\); 78%).
From the ictus to the KUH arrival
The site of SAH ictus, with vs. without eyewitnesses, was home (\(n=19\); 42% vs. 7; 16%), work (\(n=4\); 9% vs. 1; 2%), or other (\(n=11\); 24% vs. 3; 7%). The first recorded symptoms and/or signs were headache alone (\(n=9\); 20%), seizure (\(n=6\); 13%) or collapse (\(n=34\); 76%). Five (11%) patients (15. 27. 31. 38. 43.) came to the first hospital and CT on their own; only one of them (patient 15.) died (Figs. 4 and 5). For 40 (89%) patients, the ambulance came to the site after the 112 call but in only 3 (8%) instances called by the patient (6. 26. 34.). The time in minutes from the 112 call to the ambulance arrival was distributed rather equally in the five hospital districts (Figs. 1 and 2, Table 2). At the first contact, GCS was distributed as follows: 13–15 (\(n=15\); 33%), 9–12 (\(n=8\); 18%), and 3–8 (\(n=22\); 49%) (Fig. 4). The first contact clustered on Monday (Table 3), without obvious reasons.
Table 2 presents the distributions of the successive time periods according to the hospital districts. The time periods were checked for possible time point errors and for extended lengths (outliers) (Fig. 4, Table 2). Among the 22 (49%) patients with GCS 3–8 on ambulance arrival, the times to tracheal intubation (3–46–66–94–217 min) seemed prolonged in five (23%) patients: 138 min, 138 min, and 152 min with GCS 3; 119 min with GCS 7; 217 min with GCS 8; all five patients died (Fig. 4).
Suspected or verified re-bleeds until the sIA occlusion
Figure 4 illustrates the approximate time points (red asterisk) for the re-bleeds on the individual timelines, and Table 4 presents them in the six sequential time periods. Importantly, 13 (29%) patients seemed to have a re-bleed before the 112 call (Fig. 4, Table 4). Before the sIA occlusion, a total of 29 (64%) DC patients had re-bleeds, 19 (76%) of the 25 deceased patients and 10 (50%) of the 20 surviving patients (Figs. 4 and 5, Tables 1 and 4).
EVD and ICP monitoring
A total of 42 (93%) DC patients received an EVD with intraventricular ICP monitoring, in a median of five hours since the ambulance arrival to the ictus site (Fig. 4). An EVD was placed in 19 (45%) patients before the sIA occlusion and in 13 (31%) patients during the sIA clipping. Antibiotic prophylaxis (cefuroxime or cloxacillin) i.v. was routine. EVD revisions were performed in 14 (56%; \(P\) 0.01) of the 25 deceased but in only three (18%) of the 17 survivors. The median EVD duration was seven days in both groups (Table 1). Clinical meningitis was diagnosed in 9 (21%) of the 42 patients, in association with the EVD duration (median 11 vs. 8 days; \(P < 0.01\)).
Timing of the sIA occlusion in the 45 DC patients
CT angiography (CTA) at KUH was the primary method (43/45; 96%) for the diagnosis of ruptured sIA. Table 3 presents the 45 sIA occlusions (28 (62%) microsurgical vs. 17 (38%) endovascular) and the 16 (36%) aICH evacuations according to the working days and weekend days, office hours, and duty hours. Overall, 20 (44%) occlusions took place during office hours and 25 (56%; 10 endovascular) in the duty hours, including 11 (24%; 3 endovascular) during weekend days.
Occlusion of 45 sIAs and evacuation of 16 aICHs
The 28 (62%) clipped sIAs were somewhat larger (n.s.) (3–7–9–13–25 mm; nine (32%) over 10 mm) than the 17 (38%) coiled ones (3–6–7–9–10 mm) (Table 1). Of the 28 clipped sIAs, 23 (82%) were MCA bifurcation sIAs, all but one with aICH (Fig. 5, Table 1). Of the 40 aICHs, 15/40 (38%; see 14. below) were exposed during the sIA clipping, but in only 11/15 (73%) a near-total aICH evacuation (patients 9. 10. 15. 21. 22. 28. 34. 39. 40. 43. 44.) was achieved (Fig. 5). No primary DCs were performed. The methods to check the sIA occlusion and open branches were micro-Doppler and indocyanine green (ICG) angiography. Postoperative angiography was obtained in 19 (68%) of the 28 clipped sIAs. One MCA bifurcation sIA with aICH (patient 14.) was first coiled and then evacuated (Fig. 5).
Among the 17 (38%) endovascularly occluded sIAs, six (35%) were on the anterior communicating artery (ACo) and six (35%) on the internal carotid artery (ICA) (Fig. 5). Of the 17 patients, four (24%) had a CT-verified re-bleed (Fig. 5): one (patient 16.) due to catheter perforation and three (patients 1. 3. 4.) with slight residual filling.
Delayed brain injuries in the 45 DC patients
A total of 34 (76%) patients developed delayed brain injuries of various sizes, regarded as ischemic (Fig. 5), 11/20 (55%) survivors and 23/25 (92%) deceased. Of the 34 delayed brain injury patients, 18 (53%) had a ruptured MCA bifurcation sIA, all but one with aICH (Fig. 5). At least 10 (29%) delayed brain injuries were large or even hemispheric, in 2 survivors (41. 45.) and in 8 deceased (3 10 11 12 15 20 21 25). In 7 (21%; patients 9. 18. 23. 31. 38. 39. 40.) delayed brain injury patients, all with aICH and clipped MCA bifurcation sIA, an M2 branch was found occluded in the postoperative CTA or digital subtraction angiography (DSA). Only two (29%) of the seven M2 occlusions could be anticipated by micro-Doppler or ICG angiography. Intra-arterial nimodipine infusion was administered in 5 patients (11%; patients 3. 11. 27. 32. 39.). In the neurointensive care, it was at first difficult to distinguish between perihematomal edema, brain edema, and delayed ischemic brain injury. The median time from the EMS call to the apparent ischemic injury in CT or CT perfusion was 68 h. The time from the EMS call to the ambulance arrival did not associate with the development of brain ischemia (Fig. 4).
ICP and secondary DC
Overall, 14 (31%) of the 45 DC patients had a dilated pupil at some phase of the timelines (Fig. 4). The median time from the KUH admission to the DC was 65 h (Fig. 4, Table 1). Three (7%) patients (1. 5. 14.) were treated with hypothermia but none with barbiturate-induced coma. Of the 45 DCs, 42 (93%) were unilateral and 3 (7%) were frontal. The DC areas in the 25 deceased (52–85–96–113–175 cm2) and in the 20 survivors (68–84–104–114–161 cm2) were similar (Table 1); the 11 smallest sizes (IQR 25%; 52 to 84 cm2) were considered as small. ICP values (1 per 2 min) distributed similarly in the 12-h recordings before and after the DCs (Table 1). There were five (11%) DC complications: four (9%; patients 2. 24. 25. 35.) tiny subcortical ICHs in the DC area (Fig. 5) and one (patient 4.) subgaleal hematoma.
Factors associated with death among the 45 DC patients
Of the 25 (56%) deceased patients, 18 (72%) patients died in the ward of KUH or another hospital after the termination of neurointensive care due to poor prognosis. The following factors associated with death as compared to the 20 survivors (Table 1): hypertension (48% vs. 20%); seizure at ictus (24% vs. 0%); aIVH blood clot (36% vs. 10%); time from KUH arrival to aICH evacuation (1 vs. 4 median hours); endovascular sIA occlusion (56% vs. 15%); Neurointensive Care Unit (NICU) time (8 vs. 12 median days); delayed brain injury on CT or MRI (92% vs. 55%). The cohort was too small for multivariate analysis.
Outcome of the 25 surviving DC patients
Among the 20 (44%) DC survivors, six (30%; patients 32. 33. 36. 37. 44. 45.) received a shunt in a median of 49 days, all after DC (Fig. 5B). Of the 20 DC survivors, 18 received a cranioplasty (15 own frozen bone flaps; two titanium meshes; one bioactive glass). There were 15 (75%) CT and five (25%) MRI scans at about one year (Fig. 5B). They reflected (i) the lost brain areas caused by aICH and (ii) injured brain areas caused by ischemia (final brain tissue outcome).
Favorable outcome (mRS 1 or 2) in the nine surviving DC patients at three years
At three years, nine (45%; median 47 years) of the 20 DC survivors had a favorable clinical outcome (mRS 1 or 2) (Fig. 5B, Table 1). Antiepileptic medication, started in six of the nine (67%) survivors, was later discontinued in three (50%) for being seizure-free. Six (30%; patients 26. 27. 28. 32. 33. 34.) survivors returned to work (median age 49 years), all with a cranioplasty and two (33%) with a shunt. Their characteristics were GCS at first contact 4, 6, 7, 11, 12, 14 (four (67%) intubated before KUH); 3/6 (50%) re-bleeds before sIA occlusion; 3 (50%) with H&H 3 and 3 (50%) with H&H 4; no aIVH clot; 5/6 (83%) with aICH (median 25 cm3) of which 2/5 (40%; patients 28, 34) evacuated; median ventilation time 11 days; 1/6 (17%) with a tracheostomy. None of the 6 returnees had areas of new brain infarction adjacent to the bleeding site nor elsewhere (Fig. 5B).
Unfavorable outcome (mRS 3 to 5) in the 11 surviving DC patients at three years
At three years, 11 (55%; median 45 years) survivors had an unfavorable outcome, two (18%; patients 41. 45.) of whom were in hospice care, nine (82%) with a cranioplasty and four (36%) with a shunt (Fig. 5B, Table 1). Re-bleed occurred in seven of 11 (64%) before the sIA occlusion. All 11 had an aICH (median 43 cm3), and seven (64%) of them evacuated. Their median time to DC was two days, as compared to five days in those with favorable outcome. Their median ventilation time was nine days, and eight of 11 (73%) had a tracheostomy. Ischemic brain lesions developed in eight (73%) patients adjacent to the primary aICH (Fig. 5B).
Discussion
Individual timeline and serial CT/MRI panels of the 45 aSAH patients with DC during neurointensive care
We chose secondary DC (DC here) as an indicator of escalating intracranial conditions since the aSAH ictus during EMS and neurointensive care of the human CNS system, suffering from and reacting to aSAH that forces arterial blood into subarachnoid spaces (aSAH) [4, 9, 41, 42] and possibly into ventricles (aIVH) [7, 14] and brain tissue (aICH) [15]. We compiled (i) individual timeline panels since the EMS call (Fig. 4) and (ii) serial CT/MRI slice panels (Fig. 5), for the 25 deceased (1.–25.) and for the 20 survivors (26.–45.).
Our study illustrated for the clinician readers the following:
-
(a)
the swiftness (“Time is Brain”) since the 112 call and possible outliers during the EMS care followed by KUH neurointensive care until the sIA occlusion,
-
(b)
the sites and sizes of aICHs and aIVHs,
-
(c)
the development of brain edema, perihematomal edema, and ischemic brain injuries, and.
-
(d)
the extent of brain injuries and brain atrophy at about 12 months after aSAH (brain tissue outcome) in the 20 survivors (“what brain tissue is left to live and try back to work”)—not just mRS 0 to 5 [65, 84] (patient outcome).
In our eyes, the possibility to track individual patients or patient groups in the panels essentially enhances the evaluation of their clinical courses, in support of Personalized Medicine. We find that our two timeline panels and two serial CT/MRI panels present quickly much more individual information than any reasonable amount of words, figures, and graphs would convey.
“Time is Brain”—brain tissue spared or lost in brain infarction vs. aSAH
Minutes count from the first signs of brain ischemia to EMS call to ambulance to hospital to CT to thrombolytic or endoarterial recanalization—to prevent or minimize permanent brain tissue injury with swift and honed logistics [29], also with mobile stroke units [107]. The key time points and periods (onset-to-hospital, onset-to-imaging, door-to-needle, door-to-artery, and onset-to-treatment) to the recanalization are defined and recorded (see Table 2) [29, 92]. The loss of brain tissue per time unit is derived from the final brain infarct volume on CT/MRI divided by the onset-to-recanalization time [87]. Oddly, some patients have poor outcomes despite small brain infarcts after endovascular recanalization while some with larger infarcts do well [27].
In aSAH, our novel timeline panels (Fig. 4) indicate several time periods that by extended durations might (i) reduce the final brain volume and (ii) increase the brain age [21]: 112 to ambulance arrival (seizures, aspiration, hypoxia), 112 to CT (uncertain diagnosis), 112 to intubation and ventilation (aspiration, hypoxia), 112 to EVD (increased ICP, ischemia, brain edema), 112 to neurointensive care (suboptimal monitoring and therapy), 112 to sIA occlusion (exposure to re-bleed, aICH and aIVH), 112 to aICH removal (increased ICP, neuroinflammation), and 112 to DC (increased ICP, ischemia, brain edema).
Construction and optimization of the individual timeline panels
We have previously published timeline panels from the Kuopio IA Database. Importantly, each panel appeared in a journal page for full attention, not in the Supplements. In Tervonen et al. (2021), the panel of 101 shunted aSAH patients showed on a logarithmic day axis (i) when their adjustable valve shunts were installed and (ii) when and why 25 (25%) were later revised [100]. In Kurtelius et al. (2019b), the timelines on a linear age axis since birth indicated at which age aortic aneurysms were detected, 48 (1.1%) in the 4253 sIA patients and 17 (14%) in the 125 fusiform IA patients [51]. In Kurtelius et al. (2019a), the risk of sIA was analyzed in the 48 children of the 18 couples with both parents as verified sIA carriers. Six sIA family trees were illustrated with the timelines of two or three generations since the birth on a linear calendar year axis (1920–2020) [50]. In Kotikoski et al. (2021), the linear age timelines of 22 female sIA patients indicated when pre-eclampsia was diagnosed in relation to the diagnosis of unruptured sIA, aSAH, and hypertension [48].
Here, the 45 timelines started from the 112 call and ended at death (Fig. 4A) or cranioplasty (Fig. 4B). Their manual creation was arduous, picking up time points, events, and interventions from various sources, partly digital since 2004 (KUH patient files, PACS, and neurointensive care monitoring data), but also from copies of original reports and charts.
The 45 timelines were trimmed to be (in our eyes) readable (abbreviations on the time points), distinguishable (line spacing), scalable (time axis), and zoomable while fitting one journal page. The time axis here is logarithmic (Figs. 3 and 4) so that (i) the EMS events, KUH arrival, EVD, sIA occlusion, and aICH removal (minute scale) could be distinguished from (ii) the neurointensive care period with DC (day scale) and (iii) the follow-up time until death (day scale) or three years (month scale). The time points of suspected or verified re-bleeds (red) and sIA occlusions (red) were highlighted to illustrate the exposure times. The sequential time intervals (Table 2) were not labelled with colors because that (in our hands) rendered the timelines unreadable.
One challenge was to decide where to place the start line of the timelines. Here, they start from the left 112 call line (zero-minute line) and proceed to the right at different lengths for the individual time periods. The zero-minute line could be placed at another time point, such as intubation, dilated pupil, suspected re-bleed, arrival at KUH, sIA occlusion, or DC. Then, the divided timeline proceeds backwards until the 112 call and forwards until death or three years, underscoring, e.g., the times of exposure to re-bleeds. Finally, our timeline panels would benefit from simple animation tools—including a vertical line movable along the time axis to compare the time points.
Construction and optimization of the individual serial CT/MRI slice panels
Acta Neurochirurgica has published our CT slice panels, each in a journal page for full attention [5, 100]. In Tervonen et al. (2021), in the 101 shunted aSAH patients, their 101 CT slices before the shunt illustrated blood clots and sediments remaining in the lateral ventricles. The 101 CT slices were arranged according to (i) EVD (\(n=82\)) or no EVD (\(n=19\)), (ii) the days from aSAH to the shunt, and (iii) revision (\(n=25\)) or no revision (\(n=76\)). In Autio et al. (2021), the primary CT slices of 120 survivors of poor grade aSAH survivors were arranged according to their mRS (0 to 5) at three years. A total of 71 (59%) patients had aICH, the volume of which significantly predicted mRS at three years.
The KUH PACS is linked to the four Central Hospitals in Eastern Finland (Fig. 1). We were able to review and retrieve all CT and MRI scans in the five digital archives of the 45 DC patients, using their personal identity codes. For each DC patient, we chose three representative slices (before and after sIA occlusion; after DC), and for the 20 survivors the fourth slice at about 12 months (Fig. 5). There are altogether 151 slices in the two panels. Many adjustments were necessary to create (in our eyes) two readable and evaluable panels, each fitting a journal page. All 45 DC patients were placed into three vertical columns (H&H 3, 4, or 5 on admission). The 20 survivors were also placed into horizontal rows according to their mRS scale (0 to 5) at three years (Fig. 5B). Each CT slice per time point was selected to show the largest aICH or aIVH volume, perihematomal edema, and thereafter the largest area of brain infarction. The CT slice after DC also reflected the largest DC diameter. There was shortage of MRI scans, none obtained close to the admission. The addition of a 3D CTA image of each ruptured sIA would crowd the panels. CT perfusion images [89] were unreadable in small size.
Pseudonymization of the individual timelines and serial head CT/MRI slice panels
The categorical concern about the patients’ privacy is obviously one reason not to present their individual timeline and serial brain image panels in the articles on acute brain insults. In this article, we present pseudonymized data only on the 45 DC patients. The data presented here does not enable the correct attribution to an individual patient (name, personal identity code, face photo or video) without the additional information strictly kept confidential by us within the KUH Information System. For the General Data Protection Regulation (GDPR)-compliant pseudonymization [23] we excluded from the timelines, CT/MRI slice panels, tables, and texts the following individual or individualizing data: name, gender, date, month and year of aSAH, clock times, and time period lengths (except the time to death in Fig. 5B). The Kuopio IA Database does not contain face photos, and the 45 DC patients were not media personalities. Concerning (i) hostile hacking or (ii) legal hacking resistance testing, the hackers must breach the KUH Information System (immediate alarm), manage to enter various databases, and then cross-link an immense amount Finnish text and imaging data to obtain the correct personal identity code of any of the 45 DC patients. The CT/MRI slices, three or four per patient (Fig. 5), do not allow the face recognition, e.g., among the facial photos or videos in the social media. In contrast, providing the entire packs of CT or MRI slices would allow 3D face segmentation, so much so that “de-facing” algorithms have been presented [88, 101, 111].
Performance of EMS and KUH logistics until the sIA occlusion
The present 45 DC patients, 11% of the 402 H&H 3–5 patients, required swift logistics in the spread-out population served solely by KUH (Fig. 1). The mutually agreed and honed logistics with CT teleconsultation since 2004 functioned satisfactorily, also in weekdays and duty hours (Table 3) [28, 105], with a few considerations.
The 112 call dispatchers’ guidance of the ambulances seemed acceptable, with a few lengthy arrivals (Table 2) [8]. The paramedics did not intubate but could install supraglottic airway devices. In a few cases, the times to intubation in relation to GCS on ambulance arrival were lengthy (Fig. 4) [30, 46, 54, 94, 95]. The ambulances did not carry CT scanners [31, 107], considering direct transfer to KUH in case of SAH after teleconsultation. Helicopters with EMS physicians to take over after the paramedic contacts were considered case-by-case [72]. The EMS charts were hand-written, but now a national electronic platform for prehospital emergency care is being adopted [74].
Re-bleeds since the ictus until the sIA occlusion
In a Norwegian cohort of 486 aSAH patients, with the EMS logistics of the catchment area, 9.7% had re-bleeds prior to aneurysm repair, and the frequency of re-bleeds increased from H&H grades 1 to 5 [94, 95]. Among our 45 DC patients with H&H 3–5 at KUH arrival, a total of 29 (64%) patients had suspected or CT-verified re-bleed(s) until the sIA occlusion (Figs. 2 and 4, Tables 1 and 4). In studying the 29 timelines (Fig. 4) and the EMS and KUH logistics (Table 3), it is difficult to tell whether more haste would have prevented re-bleeds. From the first medical contacts, there were 31 re-bleeds or one per 22 h (Fig. 4) of the total exposure time of 671 h until the sIA occlusion. Tranexamic acid was started after the first CT. Tranexamic acid seems to reduce re-bleeds, but paradoxically, the clinical outcome would remain unchanged [75]. Significant re-bleeds may also occur during sIA clipping or endovascular occlusion [45, 115].
Re-bleeds and true incidence of aSAH in defined populations
Of our 45 DC patients, 13 (29%) had suspected or clinical re-bleeds before the first medical contact (Fig. 4, Table 4). In a Norwegian cohort, a second thunderclap headache with or without loss of consciousness and a sudden deterioration in GCS were considered a clinical re-bleed [94,95,96]. “Minor leak” just means a missed diagnosis of aSAH [68, 113]. Re-bleeds may conceal the real aSAH incidence in defined populations. Among sudden deaths outside hospital, acute aSAH is one potential cause, verifiable at autopsy [55], possibly with adjunct cadaveric CT and CT infusion angiography [40]. At autopsies, however, it may be difficult to distinct one bleed from two bleeds. Re-bleeds may worsen the patients’ clinical condition and prognosis so profoundly that they are (i) not transferred to the neurointensive care and thereby (ii) not entered into clinical aSAH databases [81].
aICH, perihematomal edema, brain ischemia, and final brain injury areas
In our DC cohort, aICHs not just (i) teared hematoma cavities within the brain tissue, later to be filled with cerebrospinal fluid (CSF), but also provoked adjacent (ii) areas of perihematomal edema [11, 34, 76] and (iii) subsequent brain injury areas [18], several of them massive. The aICHs at the MCA bifurcation proved particularly noxious for the brain [26, 93]. Of the 27 clippings with aICH, 18 (67%) started within eight hours of the 112 call, the goal time window in the present Dutch ICH Surgery Trial (NCT03608423) [91]. Intraoperative CT [35], not available, would have disclosed possible residuals. Endovascular occlusion did not spare from brain infarcts adjacent to aICHs.
Primary causes of ischemia include the tearing of small vessels by the burst of arterial blood, locally increased pressure, and brain herniation. Secondary causes of brain injury [79] include neuroinflammation [24, 44], brain edema [116], microglial activation [10], leukocyte infiltration [57, 117], perihematomal edema [76], impaired glymphatic drainage [2], delayed brain edema resolution [80, 86], delayed blood clearance [71, 73], and microemboli [12, 79]. Iatrogenic causes include manipulation, temporary artery occlusion, and accidental branch or perforator occlusion during sIA occlusions.
Strengths and limitations of the pilot study
We may be the first to illustrate all patients’ individual timeline and serial imaging panels from the EMS contact to the outcome at 12 months in any acute brain insult cohort. The strengths derive from the tax-paid Finnish health care system and the automatic archival of clinical data, using the Finnish identity codes, in the national registries. Finland is divided into exclusive catchment areas between the five university hospitals which results in cohorts that are minimally selected and biased. The Kuopio Database contains all aSAH patients admitted from Eastern Finland (Fig. 1) and allows to reconstruct their clinical timelines, including data in other hospitals and national registries [5, 100].
There are also limitations. Our pilot study is retrospective while the database was prospective in the study period. We chose secondary DC as an indicator of escalating aSAH, so the 45 patients represent only 6% of the entire aSAH study population. In retrospect, there was shortage of perfusion and MRI studies. Space did not allow to discuss in detail various aspects of aSAH along the timelines. The panels here may at the present be hard to compile in other neuroacutology services.
Of the 20 DC survivors, there were 15 CT scans and five MRI scans available at about one year (Fig. 5B). They reflected (i) the lost brain areas caused by aICH and (ii) injured brain areas. It is challenging to compare the two modalities for the final brain outcome; naturally, a much larger number of MRI scans would be preferable.
Suggested development—individual timeline and serial imaging panels to fill present knowledge gaps
-
1.
Clinical researchers and journals of acute brain insults could consider the publication—with strict and shared pseudonymization practices—of the patients’ individual (i) timeline panels from the EMS contact and (ii) serial brain imaging panels until at least 12 months. This approach would support Personalized Acute Care. Any findings associated with the final brain outcome could be supported with the serial imaging panels [109, 118]. Such illustrative panels—with basic animation—require user-friendly interfaces with timeline construction tools.
-
2.
Acute brain insult databases with individual timelines and serial imaging could create national and international registries with constant accrual from the allied institutes, including digital radiology, histology and genomics, and biobanking of tissue specimen. Such registries may allow in silico and virtual randomized clinical trials (RCTs) [62] in comparison to more laborious RCTs, as well as re-analysis of pseudonymized “raw data.”
-
3.
Machine learning (ML) reading of acute and serial neuroimaging (CT CTA MR MRA perfusion) in daily clinical use could depend on such databases and registries as ML teaching resources, including outcome predictions [17, 60].
-
4.
The IT systems of the hospital catchment area and allied stakeholders should provide individual timelines (in minute scale) from multiple data sources, since the EMS contact through the (neuro)intensive care until the final outcome. At EMS phase, the patient’s timeline should proceed near real time on the monitoring screens.
-
5.
Any branch of acute or elective Personalized Care will benefit from the individual timelining and serial imaging, e.g., in daily practice, follow-up, quality control for timely and equal access to clinical services, and cost analysis. Such transparent analyses of data may illustrate information, mechanisms, and causal relations, possibly overlooked or not presented before. With tens, hundreds, or thousands of individual timelines on the screen, new tools for visual dissective and comparative multivariate analysis are required.
Suggested further research and development—aneurysmal SAH
Today, clinical research on aSAH is hampered by generalizations and inexact scales of volume, causality, and kinetics of events. For example, “vasospasm” is jargon for delayed ischemic injury, simplifying pathogenesis and potentially misguiding scientific understanding [6, 12, 79, 112]. Grading of subarachnoid blood with the modified Fisher scale [61] fails to specify the aICH and aIVH “clots.” With the present approach, the analysis of individual blood distribution and 3D angiographies to detect which main trunks and segments really become “vasospastic’” in the patient’s timeline and how that correlate in (i) perfusion studies and (ii) final brain outcome [3, 16, 90] in the machine learning (ML) analysis becomes feasible.
The contents of (i) early ischemic brain areas and (ii) perihematomal edema areas could be studied in detail with ex vivo MRI combined with histopathology [36, 103] in aSAH patients who succumbed during their neurointensive care. It remains to be seen how salvable these “penumbral” areas become with novel therapies [32, 53, 77, 96].
To reduce neuroinflammation—within reason—blood burden [70, 93] could be promptly (i) released from aICH cavities and (ii) rinsed with catheters from cisterns [25] and ventricles [43, 49, 85, 102]. Continuous infusion of novel drugs into main cerebral arteries, cisterns, and ventricles is conceivable [43, 63].
Clinical conclusions
In our pilot study, the pseudonymized timeline panels and serial brain imaging panels, indicating the patients by numbers, allowed the presentation and comparison of individual clinical courses. An obvious application would be the quality control in acute or elective medicine for timely and equal access to clinical care, in support of Personalized Medicine.
Consent, data, material, and/or code availability
All research consents, data, material, and coding are available for corresponding author.
Data Availability
Major parts of our data are derived from Finnish national health registries, which are regulated by the Finnish Institute of Health and Welfare. By their strict instructions, we are not allowed to share our datasets openly in any form due to privacy requirements of Finnish law. Interested researchers can be granted permission to our datasets by individual evaluation and the final permission will be granted by Institute of Health and Welfare.
Abbreviations
- ACA::
-
Anterior cerebral artery
- ACo::
-
Anterior communicating artery
- aICH::
-
Aneurysmal intracerebral hemorrhage
- aIVH::
-
Aneurysmal intraventricular hemorrhage
- aSAH::
-
Aneurysmal subarachnoid hemorrhage
- aSDH::
-
Acute subdural hemorrhage from aSAH
- CH::
-
Central Hospital
- clip::
-
Microsurgical occlusion
- clipped::
-
Microsurgical occlusion
- CNS::
-
Central nervous system
- coil::
-
Endovascular occlusion
- coiled::
-
Endovascular occlusion
- CSF::
-
Cerebrospinal fluid
- CT::
-
Computed tomography
- CTA::
-
CT angiography
- dBI::
-
Delayed brain injury
- DC::
-
Decompressive craniectomy
- DSA::
-
Digital subtraction angiography
- eICH::
-
Evacuation of aICH
- EMS::
-
Emergency medical services
- eSDH::
-
Evacuation of aSDH
- EVD::
-
Extraventricular drainage
- GCS::
-
Glasgow Coma Scale
- GDPR::
-
General Data Protection Regulation
- GPS::
-
Global Positioning System
- H&H::
-
Hunt & Hess scale
- HEMS::
-
Helicopter emergency medical services
- IA::
-
Intracranial aneurysm
- ICA::
-
Internal carotid artery trunk and bifurcation
- ICG::
-
Indocyanine green
- ICH::
-
Intracerebral hemorrhage
- ICP::
-
Intracranial pressure
- ICU::
-
Intensive care unit
- IQR::
-
25% And 75% range
- IVH::
-
Intraventricular hemorrhage
- Jo CH::
-
Joensuu Central Hospital
- Jy CH::
-
Jyväskylä Central Hospital
- km::
-
Kilometer
- KUH::
-
Kuopio University Hospital
- M1::
-
M1 segment of the middle cerebral artery
- Mbif::
-
Middle cerebral artery bifurcation
- Mi CH::
-
Mikkeli Central Hospital
- ML::
-
Machine learning
- MRI::
-
Magnetic resonance imaging
- mRS::
-
Modified Rankin Scale
- n.a.::
-
Not applicable
- n.r.::
-
Not relevant
- n.s.::
-
Not significant
- NICU::
-
Neurointensive Care Unit
- PACS::
-
Digital image archive
- PCo::
-
Posterior communicating artery
- RCT::
-
Randomized clinical trial
- Sa CH::
-
Savonlinna Central Hospital
- SAH::
-
Subarachnoid hemorrhage
- Sh::
-
Shunt
- sIA::
-
Saccular intracranial aneurysm
- TBI::
-
Traumatic brain injury
References
Adams H, Ban VS, Leinonen V, Aoun SG, Huttunen J, Saavalainen T, Lindgren A, Frosen J, von Und Zu, Fraunberg M, Koivisto T, Hernesniemi J, Welch BG, Jääskeläinen JE, Huttunen TJ (2016) Risk of shunting after aneurysmal subarachnoid hemorrhage: a collaborative study and initiation of a consortium. Stroke 47:2488–2496
Akins PT, Guppy KH (2021) Does impaired glymphatic drainage cause glymphedema? A review tailored to neurocritical care and neurosurgery. Neurocrit Care 35:545–558
Allen JW, Prater A, Kallas O, Abidi SA, Howard BM, Tong F, Agarwal S, Yaghi S, Dehkharghani S (2022) Diagnostic performance of computed tomography angiography and computed tomography perfusion tissue time-to-maximum in vasospasm following aneurysmal subarachnoid hemorrhage. J Am Heart Assoc. https://doi.org/10.1161/JAHA.121.023828
Alotaibi NM, Elkarim GA, Samuel N, Ayling OGS, Guha D, Fallah A, Aldakkan A, Jaja BNR, de Oliveira Manoel AL, Ibrahim GM, Macdonald RL (2017) Effects of decompressive craniectomy on functional outcomes and death in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg 127:1315–1325
Autio AH, Paavola J, Tervonen J, Lång M, Huuskonen TJ, Huttunen J, Kärkkäinen V, von Und Zu, Fraunberg M, Lindgren AE, Koivisto T, Jääskeläinen JE, Kämäräinen OP (2021) Clinical condition of 120 patients alive at 3 years after poor-grade aneurysmal subarachnoid hemorrhage. Acta Neurochir 163:1153–1166
Behrouz R (2019) The rise and fall of transcranial doppler ultrasonography for the diagnosis of vasospasm in aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 31:79–80
Bisson DA, Flaherty ML, Shatil AS, Gladstone D, Dowlatshahi D, Carrozzella J, Zhang L, Hill MD, Demchuck A, Aviv RI, STOP-IT and SPOTLIGHT Investigators (2020) Original and modified Graeb score correlation with intraventricular hemorrhage and clinical outcome prediction in hyperacute intracranial hemorrhage. Stroke 51:1696–1702
Blomberg SN, Christensen HC, Lippert F, Ersbøll AK, Torp-Petersen C, Sayre MR, Kudenchuk PJ, Folke F (2021) Effect of machine learning on dispatcher recognition of out-of-hospital cardiac arrest during calls to emergency medical services: a randomized clinical trial. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2020.32320
Brandecker S, Hadjiathanasiou A, Kern T, Schuss P, Vatter H, Güresir E (2021) Primary decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage: long-term outcome in a single-center study and systematic review of literature. Neurosurg Rev 44:2153–2162
Chen J, Zheng ZV, Lu G, Chan WY, Zhang Y, Wong GKC (2022) Microglia activation, classification and microglia-mediated neuroinflammatory modulators in subarachnoid hemorrhage. Neural Regen Res 17:1404–1411
Chen Y, Chen S, Chang J, Wei J, Feng M, Wang R (2021) Perihematomal edema after intracerebral hemorrhage: an update on pathogenesis, risk factors, and therapeutic advances. Front Immunol. https://doi.org/10.3389/fimmu.2021.740632
Clarke JV, Suggs JM, Diwan D, Lee JV, Lipsey K, Vellimana AK, Zipfel GJ (2020) Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: a review and synthesis. J Cereb Blood Flow Metab 40:1565–1575
Darkwah Oppong M, Bastias MJ, Pierscianek D, Droste L, Dinger TF, Ahmadipour Y, Rauschenbach L, Quesada C, Chihi M, Dammann P, Forsting M, Wrede KH, Sure U, Jabbarli R (2021) Seizures at the onset of aneurysmal SAH: epiphenomenon or valuable predictor? J Neurol 268:493–501
Darkwah Oppong M, Gembruch O, Herten A, Frantsev R, Chihi M, Dammann P, El Hindy N, Forsting M, Sure U, Jabbarli R (2018) Intraventricular hemorrhage caused by subarachnoid hemorrhage: does the severity matter? World Neurosurg 111:693–702
Darkwah Oppong M, Skowronek V, Pierscianek D, Gembruch O, Herten A, Saban DV, Dammann P, Forsting M, Sure U, Jabbarli R (2018) Aneurysmal intracerebral hematoma: risk factors and surgical treatment decisions. Clin Neurol Neurosurg 173:1–7
Darsaut TE, Derksen C, Farzin B, Keough MB, Fahed R, Boisseau W, Letourneau-Guillon L, Januel AC, Weill A, Roy D, Nguyen TN, Finitsis S, Gentric JC, Volders D, Carlson A, Chow MM, O’Kelly C, Rempel JL, Ashforth RA, Chagnon M, Zehr J, Findlay JM, Gevry G, Raymond J (2021) Reliability of the diagnosis of cerebral vasospasm using catheter cerebral angiography: a systematic review and inter- and intraobserver study. AJNR Am J Neuroradiol 42:501–507
Dengler NF, Madai VI, Unteroberdörster M, Zihni E, Brune SC, Hilbert A, Livne M, Wolf S, Vajkoczy P, Frey D (2021) Outcome prediction in aneurysmal subarachnoid hemorrhage: a comparison of machine learning methods and established clinico-radiological scores. Neurosurg Rev 44:2837–2846
Dodd WS, Laurent D, Dumont AS, Hasan DM, Jabbour PM, Starke RM, Hosaka K, Polifka AJ, Hoh BL, Chalouhi N (2021) Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc. https://doi.org/10.1161/JAHA.121.021845
Dreier JP, Winkler MKL, Major S, Horst V, Lublinsky S, Kola V, Lemale CL, Kang EJ, Maslarova A, Salur I, Lückl J, Platz J, Jorks D, Oliveira-Ferreira AI, Schoknecht K, Reiffurth C, Milakara D, Wiesenthal D, Hecht N, Dengler NF, Liotta A, Wolf S, Kowoll CM, Schulte AP, Santos E, Güresir E, Unterberg AW, Sarrafzadeh A, Sakowitz OW, Vatter H, Reiner M, Brinker G, Dohmen C, Shelef I, Bohner G, Scheel M, Vajkoczy P, Hartings JA, Friedman A, Martus P, Woitzik J (2022) Spreading depolarizations in ischaemia after subarachnoid haemorrhage, a diagnostic phase III study. Brain 145:1264–1284
Eagles ME, Tso MK, Ayling OGS, Wong JH, MacDonald RL (2020) Unfavorable outcome after good grade aneurysmal subarachnoid hemorrhage: exploratory analysis. World Neurosurg 144:842–848
Egorova N, Liem F, Hachinski V, Brodtmann A (2019) Predicted brain age after stroke. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2019.00348
Engquist H, Lewén A, Hillered L, Ronne-Engström E, Nilsson P, Enblad P, Rostami E (2020) CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage. J Neurosurg 10:1–10
European Data Protection Board (2022) Guidelines 02/2022 on the application of Article 60 GDPR Version 1.0 Adopted on 14 March 2022 https://edpb.europa.eu/system/files/2022-03/guidelines_202202_on_the_application_of_article_60_gdpr_en.pdf. Accessed 8 Jul 2022
Fam MD, Zeineddine HA, Eliyas JK, Stadnik A, Jesselson M, McBee N, Lane K, Cao Y, Wu M, Zhang L, Thompson RE, John S, Ziai W, Hanley DF, Awad IA, Trial Investigators CLEARIII (2017) CSF inflammatory response after intraventricular hemorrhage. Neurology 89:1553–1560
Fistouris P, Scheiwe C, Grauvogel J, Csók I, Beck J, Reinacher PC, Roelz R (2022) Mitigation of blood load impact in patients with subarachnoid hemorrhage by cisternal lavage. Cerebrovasc Dis. https://doi.org/10.1159/000521203
Galea I, Durnford A, Glazier J, Mitchell S, Kohli S, Foulkes L, Norman J, Darekar A, Love S, Bulters DO, Nicoll JAR, Boche D (2022) Iron deposition in the brain after aneurysmal subarachnoid hemorrhage. Stroke 53:1633–1642
Ganesh A, Ospel JM, Menon BK, Demchuk AM, McTaggart RA, Nogueira RG, Poppe AY, Almekhlafi MA, Hanel RA, Thomalla G, Holmin S, Puetz V, van Adel BA, Tarpley JW, Tymianski M, Hill MD, Goyal M, ESCAPE-NA1 Trial Investigators (2021) Assessment of discrepancies between follow-up infarct volume and 90-day outcomes among patients with ischemic stroke who received endovascular therapy. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.32376
Goertz L, Kabbasch C, Pflaeging M, Pennig L, Laukamp KR, Timmer M, Styczen H, Brinker G, Goldbrunner R, Krischek B (2021) Impact of the weekend effect on outcome after microsurgical clipping of ruptured intracranial aneurysms. Acta Neurochir 163:783–791
Goyal M, Saver JL, Ganesh A, McDonough RV, Roos Y, Boulouis G, Kurz M, Psychogios M, Holmin S, Majoie C, Bourcier R, Chandra R, Yoshimura S, Yavagal D, Gory B, Taschner C, Buck B, Jadhav A, Hill MD, Ospel JM (2021) Standardized reporting of workflow metrics in acute ischemic stroke treatment: why and how? Stroke Vasc Interv Neurol. https://doi.org/10.1161/SVIN.121.000177
Gravesteijn BY, Sewalt CA, Ercole A, Lecky F, Menon D, Steyerberg EW, Maas AIR, Lingsma HF, Klimek M, CENTER-TBI collaborators (2020) Variation in the practice of tracheal intubation in Europe after traumatic brain injury: a prospective cohort study. Anaesthesia 75:45–53
Grotta JC, Yamal JM, Parker SA, Rajan SS, Gonzales NR, Jones WJ, Alexandrov AW, Navi BB, Nour M, Spokoyny I, Mackey J, Persse D, Jacob AP, Wang M, Singh N, Alexandrov AV, Fink ME, Saver JL, English J, Barazangi N, Bratina PL, Gonzalez M, Schimpf BD, Ackerson K, Sherman C, Lerario M, Mir S, Im J, Willey JZ, Chiu D, Eisshofer M, Miller J, Ornelas D, Rhudy JP, Brown KM, Villareal BM, Gausche-Hill M, Bosson N, Gilbert G, Collins SQ, Silnes K, Volpi J, Misra V, McCarthy J, Flanagan T, Rao CPV, Kass JS, Griffin L, Rangel-Gutierrez N, Lechuga E, Stephenson J, Phan K, Sanders Y, Noser EA (2021) Bowry R (2021) Prospective, multicenter, controlled trial of mobile stroke units. N Engl J Med 385:971–981
Güresir E, Lampmann T, Bele S, Czabanka M, Czorlich P, Gempt J, Goldbrunner R, Hurth H, Hermann E, Jabbarli R, Krauthausen M, König R, Lindner D, Malinova V, Meixensberger J, Mielke D, Németh R, Darkwah Oppong M, Pala A, Prinz V, Rashidi A, Roder C, Sandalcioglu IE, Sauvigny T, Schebesch KM, Timmer M, Vajkoczy P, Wessels L, Wild F, Wilhelm C, Wostrack M, Vatter H, Coch C (2022) Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: study protocol for a randomized controlled trial. Int J Stroke. https://doi.org/10.1177/17474930221093501
Göttsche J, Flottmann F, Jank L, Thomalla G, Rimmele DL, Czorlich P, Westphal M, Regelsberger J (2020) Decompressive craniectomy in malignant MCA infarction in times of mechanical thrombectomy. Acta Neurochir 162:3147–3152
Haupenthal D, Kuramatsu JB, Volbers B, Sembill JA, Mrochen A, Balk S, Hoelter P, Lücking H, Engelhorn T, Dörfler A, Schwab S, Huttner HB, Sprügel MI (2021) Disability-adjusted life-years associated with intracerebral hemorrhage and secondary Injury. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.15859
Hecht N, Czabanka M, Kendlbacher P, Raff JH, Bohner G, Vajkoczy P (2020) Intraoperative CT and cone-beam CT imaging for minimally invasive evacuation of spontaneous intracerebral hemorrhage. Acta Neurochir 162:3167–3177
Hokari M, Shimbo D, Uchida K, Gekka M, Asaoka K, Itamoto K (2022) Characteristics of MRI findings after subarachnoid hemorrhage and D-dimer as a predictive value for early brain injury. J Stroke Cerebrovasc Dis. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106073
Hutchinson PJ, Kolias AG, Tajsic T, Adeleye A, Aklilu AT, Apriawan T, Bajamal AH, Barthélemy EJ, Devi BI, Bhat D, Bulters D, Chesnut R, Citerio G, Cooper DJ, Czosnyka M, Edem I, El-Ghandour NMF, Figaji A, Fountas KN, Gallagher C, Hawryluk GWJ, Iaccarino C, Joseph M, Khan T, Laeke T, Levchenko O, Liu B, Liu W, Maas A, Manley GT, Manson P, Mazzeo AT, Menon DK, Michael DB, Muehlschlegel S, Okonkwo DO, Park KB, Rosenfeld JV, Rosseau G, Rubiano AM, Shabani HK, Stocchetti N, Timmons SD, Timofeev I, Uff C, Ullman JS, Valadka A, Waran V, Wells A, Wilson MH, Servadei F (2019) Consensus statement from the International Consensus Meeting on the role of decompressive craniectomy in the management of traumatic brain injury : consensus statement. Acta Neurochir 161:1261–1274
Huttunen J, Kurki MI, von Und Zu, Fraunberg M, Koivisto T, Ronkainen A, Rinne J, Jääskeläinen JE, Kälviäinen R, Immonen A (2015) Epilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study. Neurology 84:2229–2237
Huttunen J, Lindgren A, Kurki MI, Huttunen T, Frösen J, von Und Zu, Fraunberg M, Koivisto T, Kälviäinen R, Räikkönen K, Viinamäki H, Jääskeläinen JE, Immonen A (2016) Antidepressant use after aneurysmal subarachnoid hemorrhage: a population-based case-control study. Stroke 47:2242–2248
Inokuchi G, Yajima D, Hayakawa M, Motomura A, Chiba F, Torimitsu S, Makino Y, Iwase H (2014) Postmortem dynamic cerebral angiography for detecting aneurysm and bleeding sites in cases of subarachnoid hemorrhage. Forensic Sci Med Pathol 10:487–495
Jabbarli R, Darkwah Oppong M, Dammann P, Wrede KH, El Hindy N, Özkan N, Müller O, Forsting M, Sure U (2017) Time is brain! Analysis of 245 cases with decompressive craniectomy due to subarachnoid hemorrhage. World Neurosurg 98:689–694
Jabbarli R, Darkwah Oppong M, Roelz R, Pierscianek D, Shah M, Dammann P, Scheiwe C, Kaier K, Wrede KH, Beck J, Sure U (2020) The PRESSURE score to predict decompressive craniectomy after aneurysmal subarachnoid haemorrhage. Brain Commun. https://doi.org/10.1093/braincomms/fcaa134
Jahromi BR, Tanskanen P, Koski-Pàlken A, Schwartz C, Koroknay-Pal P, Romo I, Niemelä M, Jari Siironen J (2021) Active cerebrospinal fluid exchange system for treatment of pyogenic ventriculitis. Neurosurgery Open 2:1–6
Karimy JK, Reeves BC, Damisah E, Duy PQ, Antwi P, David W, Wang K, Schiff SJ, Limbrick DD Jr, Alper SL, Warf BC, Nedergaard M, Simard JM, Kahle KT (2020) Inflammation in acquired hydrocephalus: pathogenic mechanisms and therapeutic targets. Nat Rev Neurol 16:285–296
Kim D, Pyen J, Whang K, Cho S, Jang Y, Kim J, Koo Y, Choi J (2022) Factors associated with rebleeding after coil embolization in patients with aneurysmal subarachnoid hemorrhage. J Cerebrovasc Endovasc Neurosurg 24:36–43
Kondziella D, Bender A, Diserens K, van Erp W, Estraneo A, Formisano R, Laureys S, Naccache L, Ozturk S, Rohaut B, Sitt JD, Stender J, Tiainen M, Rossetti AO, Gosseries O, Chatelle C, EAN Panel on Coma, Disorders of Consciousness (2020) European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness. Eur J Neurol 27:741–756
Kotikoski S, Huttunen J, Huttunen TJ, Helin K, Frösen J, Koivisto T, Kurki MI, von Und Zu, Fraunberg M, Kunnamo I, Jääskeläinen JE, Lindgren AE (2018) Secondary hypertension in patients with saccular intracranial aneurysm disease: a population based study. PLoS One. https://doi.org/10.1371/journal.pone.0206432
Kotikoski S, Kurtelius A, Nurmonen HJ, Paavola J, Kärkkäinen V, Huuskonen TJ, Huttunen J, Koivisto T, von Und Zu, Fraunberg M, Jääskeläinen JE, Lindgren AE (2022) Pre-eclampsia, gestational diabetes and hypertensive disorders in patients with intracranial aneurysms: a case-control study. Eur J Neurol 29:199–207
Kuo LT, Huang AP (2021) The pathogenesis of hydrocephalus following aneurysmal subarachnoid hemorrhage. Int J Mol Sci. https://doi.org/10.3390/ijms22095050
Kurtelius A, Kurki MI, von Und Zu, Fraunberg M, Väntti N, Kotikoski S, Nurmonen H, Koivisto T, Jääskeläinen JE, Lindgren AE (2019) Saccular intracranial aneurysms in children when both parents are sporadic or familial carriers of saccular intracranial aneurysms. Neuroepidemiology 52:47–54
Kurtelius A, Väntti N, Jahromi BR, Tähtinen O, Manninen H, Koskenvuo J, Tulamo R, Kotikoski S, Nurmonen H, Kämäräinen OP, Huttunen T, Huttunen J, von Und Zu, Fraunberg M, Koivisto T, Jääskeläinen JE, Lindgren AE (2019) Association of intracranial aneurysms with aortic aneurysms in 125 patients with fusiform and 4253 patients with saccular intracranial aneurysms and their family members and population controls. J Am Heart Assoc. https://doi.org/10.1161/JAHA.119.013277
Kämäräinen OP, Huttunen J, Lindgren A, Lång M, Bendel S, Uusaro A, Parviainen I, Koivisto T, Isoniemi H, Jääskeläinen JE (2018) Identification of potential organ donors after aneurysmal subarachnoid hemorrhage in a population-based neurointensive care in Eastern Finland. Acta Neurochir 160:1507–1514
Labeyrie MA, Simonato D, Gargalas S, Morisson L, Cortese J, Ganau M, Fuschi M, Patel J, Froelich S, Gaugain S, Chousterman B, Houdart E (2021) Intensive therapies of delayed cerebral ischemia after subarachnoid hemorrhage: a propensity-matched comparison of different center-driven strategies. Acta Neurochir 163:2723–2731
Lashkarivand A, Sorteberg W, Rosseland LA, Sorteberg A (2020) Survival and outcome in patients with aneurysmal subarachnoid hemorrhage in Glasgow coma score 3–5. Acta Neurochir 162:533–544
Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M (2017) Risk factors of sudden death from subarachnoid hemorrhage. Stroke 48:2399–2404
Lindlöf M, Lindgren A, Paavola J, Väntti N, von Und Zu, Fraunberg M, Koivisto T, Jääskeläinen JE, Kämäräinen OP, Huttunen J (2019) Analgesic use after aneurysmal subarachnoid hemorrhage: a population-based case-control study of 1187 patients. World Neurosurg 126:1276–1286
Li Z, Li M, Shi SX, Yao N, Cheng X, Guo A, Zhu Z, Zhang X, Liu Q (2020) Brain transforms natural killer cells that exacerbate brain edema after intracerebral hemorrhage. J Exp Med. https://doi.org/10.1084/jem.20200213
Maas WJ, Lahr MMH, Uyttenboogaart M, Buskens E, van der Zee DJ, CONTRAST investigators (2022) Expediting workflow in the acute stroke pathway for endovascular thrombectomy in the northern Netherlands: a simulation model. BMJ Open. https://doi.org/10.1136/bmjopen-2021-056415
Maher M, Schweizer TA, Macdonald RL (2020) Treatment of spontaneous subarachnoid hemorrhage: guidelines and gaps. Stroke 51:1326–1332
Maldaner N, Zeitlberger AM, Sosnova M, Goldberg J, Fung C, Bervini D, May A, Bijlenga P, Schaller K, Roethlisberger M, Rychen J, Zumofen DW, D’Alonzo D, Marbacher S, Fandino J, Daniel RT, Burkhardt JK, Chiappini A, Robert T, Schatlo B, Schmid J, Maduri R, Staartjes VE, Seule MA, Weyerbrock A, Serra C, Stienen MN, Bozinov O, Regli L (2021) Development of a complication- and treatment-aware prediction model for favorable functional outcome in aneurysmal subarachnoid hemorrhage based on machine learning. Neurosurgery 88:150–157
Melinosky C, Kincaid H, Claassen J, Parikh G, Badjatia N, Morris NA (2021) The modified Fisher scale lacks interrater reliability. Neurocrit Care 35:72–78
Miller C, Padmos RM, van der Kolk M, Józsa TI, Samuels N, Xue Y, Payne SJ, Hoekstra AG (2021) In silico trials for treatment of acute ischemic stroke: design and implementation. Comput Biol Med. https://doi.org/10.1016/j.compbiomed.2021.104802
Muhammad S, Hänggi D (2021) Inflammation and anti-inflammatory targets after aneurysmal subarachnoid hemorrhage. Int J Mol Sci. https://doi.org/10.3390/ijms22147355
Neifert SN, Chapman EK, Martini ML, Shuman WH, Schupper AJ, Oermann EK, Mocco J, Macdonald RL (2021) Aneurysmal subarachnoid hemorrhage: the last decade. Transl Stroke Res 12:428–446
Nobels-Janssen E, Postma EN, Abma IL, van Dijk JMC, Haeren R, Schenck H, Moojen WA, den Hertog MH, Nanda D, Potgieser ARE, Coert BA, Verhagen WIM, Bartels RHMA, van der Wees PJ, Verbaan D, Boogaarts HD (2022) Inter-method reliability of the modified Rankin Scale in patients with subarachnoid hemorrhage. J Neurol 269:2734–2742
Nurmonen HJ, Huttunen T, Huttunen J, Kurki MI, Helin K, Koivisto T, von Und Zu, Fraunberg M, Jääskeläinen JE, Lindgren AE (2017) Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population. Neurology 89:1852–1859
Nurmonen HJ, Huttunen T, Huttunen J, Kurtelius A, Kotikoski S, Junkkari A, Koivisto T, von Und Zu, Fraunberg M, Kämäräinen OP, Lång M, Isoniemi H, Jääskeläinen JE, Lindgren AE (2020) Lack of impact of polycystic kidney disease on the outcome of aneurysmal subarachnoid hemorrhage: a matched case-control study. J Neurosurg 134:1871–1878
Oda S, Shimoda M, Hirayama A, Imai M, Komatsu F, Shigematsu H, Nishiyama J, Matsumae M (2015) Neuroradiologic diagnosis of minor leak prior to major SAH: diagnosis by T1-FLAIR mismatch. AJNR Am J Neuroradiol 36:1616–1622
Paavola JT, Väntti N, Junkkari A, Huttunen TJ, von Und Zu, Fraunberg M, Koivisto T, Kämäräinen OP, Lång M, Meretoja A, Räikkönen K, Viinamäki H, Jääskeläinen JE, Huttunen J, Lindgren AE (2019) Antipsychotic use among 1144 patients after aneurysmal subarachnoid hemorrhage. Stroke 50:1711–1718
Panni P, Colombo E, Donofrio CA, Barzaghi LR, Albano L, Righi C, Scomazzoni F, Simionato F, Mortini P, Falini A, Anzalone N (2019) Hemorrhagic burden in poor-grade aneurysmal subarachnoid hemorrhage: a volumetric analysis of different bleeding distributions. Acta Neurochir 161:791–797
Pan P, Xu L, Zhang H, Liu Y, Lu X, Chen G, Tang H, Wu J (2020) A review of hematoma components clearance mechanism after subarachnoid hemorrhage. Front Neurosci. https://doi.org/10.3389/fnins.2020.00685
Pappinen J, Miettinen T, Laukkanen-Nevala P, Jäkälä P, Kantanen AM, Mäntyselkä P, Kurola J (2020) The selection of an optimal transportation strategy in urgent stroke missions: a simulation study. Scand J Trauma Resusc Emerg Med. https://doi.org/10.1186/s13049-020-00747-4
Park HG, Kim S, Chung J, Jang CK, Park KY, Lee JW (2021) Intraventricular hemorrhage clot clearance rate as an outcome predictor in patients with aneurysmal subarachnoid hemorrhage: a retrospective study. BMC Neurol. https://doi.org/10.1186/s12883-021-02505-0
Paulin J, Reunamo A, Kurola J, Moen H, Salanterä S, Riihimäki H, Vesanen T, Koivisto M, Iirola T (2022) Using machine learning to predict subsequent events after EMS non-conveyance decisions. BMC Med Inform Decis Mak. https://doi.org/10.1186/s12911-022-01901-x
Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, van de Vlekkert J, Bienfait HP, Boogaarts HD, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D, Investigators ULTRA (2021) Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet 397:112–118
Puy L, Perbet R, Figeac M, Duchêne B, Deramecourt V, Cordonnier C, Bérézowski V (2022) Brain peri-hematomal area, a strategic interface for blood clearance: a human neuropathological and transcriptomic study. Stroke 53:2026–2035
Qureshi AI, Lobanova I, Huang W, Ishfaq MF, Broderick JP, Cassarly CN, Martin RH, Macdonald RL, Suarez JI (2022) Lessons learned from phase ii and phase iii trials investigating therapeutic agents for cerebral ischemia associated with aneurysmal subarachnoid hemorrhage. Neurocrit Care 36:662–681
Raj R, Bendel S, Reinikainen M, Hoppu S, Laitio R, Ala-Kokko T, Curtze S, Skrifvars MB (2018) Costs, outcome and cost-effectiveness of neurocritical care: a multi-center observational study. Crit Care. https://doi.org/10.1186/s13054-018-2151-5
Rass V, Helbok R (2021) How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage. Curr Opin Crit Care 27:103–114
Rass V, Ianosi BA, Wegmann A, Gaasch M, Schiefecker AJ, Kofler M, Lindner A, Addis A, Almashad SS, Rhomberg P, Pfausler B, Beer R, Gizewski ER, Thomé C, Helbok R (2019) Delayed resolution of cerebral edema is associated with poor outcome after nontraumatic subarachnoid hemorrhage. Stroke 50:828–836
Rautalin I, Lindbohm JV, Kaprio J, Korja M (2021) Substantial within-country variation in the incidence of subarachnoid hemorrhage: a nationwide Finnish study. Neurology 97:52–60
Ravishankar N, Nuoman R, Amuluru K, El-Ghanem M, Thulasi V, Dangayach NS, Lee K, Al-Mufti F (2020) Management strategies for intracranial pressure crises in subarachnoid hemorrhage. J Intensive Care Med 35:211–218
Rawal S, Rinkel GJE, Fang J, Washington CW, Macdonald RL, Victor JC, Krings T, Kapral MK, Laupacis A (2021) External validation and modification of nationwide inpatient sample subarachnoid hemorrhage severity score. Neurosurgery 89:591–596
Rebchuk AD, O’Neill ZR, Szefer EK, Hill MD, Field TS (2020) Health utility weighting of the modified rankin scale: a systematic review and meta-analysis. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2020.3767
Ritzenthaler T, Gobert F, Bouchier B, Dailler F (2021) Amount of blood during the subacute phase and clot clearance rate as prognostic factors for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Clin Neurosci 87:74–79
Said M, Gümüs M, Herten A, Dinger TF, Chihi M, Darkwah Oppong M, Deuschl C, Wrede KH, Kleinschnitz C, Sure U, Jabbarli R (2021) Subarachnoid Hemorrhage Early Brain Edema Score (SEBES) as a radiographic marker of clinically relevant intracranial hypertension and unfavorable outcome after subarachnoid hemorrhage. Eur J Neurol 28:4051–4059
Saver JL (2006) Time is brain–quantified. Stroke 37:263–266
Schwarz CG, Kremers WK, Wiste HJ, Gunter JL, Vemuri P, Spychalla AJ, Kantarci K, Schultz AP, Sperling RA, Knopman DS, Petersen RC, Jack CR Jr, Alzheimer’s Disease Neuroimaging Initiative (2021) Changing the face of neuroimaging research: comparing a new MRI de-facing technique with popular alternatives. Neuroimage. https://doi.org/10.1016/j.neuroimage.2021.117845
Shi D, Jin D, Cai W, Zhu Q, Dou X, Fan G, Shen J, Xu L (2020) Serial low-dose quantitative CT perfusion for the evaluation of delayed cerebral ischaemia following aneurysmal subarachnoid haemorrhage. Clin Radiol 75:131–139
Simonato D, Borchert RJ, Vallee F, Joachim J, Civelli V, Cancian L, Houdart E, Labeyrie MA (2021) Distribution of symptomatic cerebral vasospasm following subarachnoid hemorrhage assessed using cone-beam CT angiography. J Neurointerv Surg. https://doi.org/10.1136/neurintsurg-2021-018080
Sondag L, Jacobs FA, Schreuder FH, Boogaarts JD, Peter Vandertop W, Dammers R, Klijn CJ (2021) Variation in medical management and neurosurgical treatment of patients with supratentorial spontaneous intracerebral haemorrhage. Eur Stroke J 6:134–142
Stojanovski B, Monagle PT, Mosley I, Churilov L, Newall F, Hocking G, Mackay MT (2017) Prehospital emergency care in childhood arterial ischemic stroke. Stroke 48:1095–1097
Stokum JA, Cannarsa GJ, Wessell AP, Shea P, Wenger N, Simard JM (2021) When the blood hits your brain: the neurotoxicity of extravasated blood. Int J Mol Sci. https://doi.org/10.3390/ijms22105132
Sorteberg A, Bredmose PP, Hansen AE, Sorteberg W (2019) The path from ictus to Neurosurgery: chronology and transport logistics of patients with aneurysmal subarachnoid haemorrhage in the South-Eastern Norway Health Region. Acta Neurochir 161:1497–1506
Sorteberg A, Romundstad L, Sorteberg W (2021) Timelines and rebleeds in patients admitted into neurosurgical care for aneurysmal subarachnoid haemorrhage. Acta Neurochir 163:771–781
Suwatcharangkoon S, Meyers E, Falo C, Schmidt JM, Agarwal S, Claassen J, Mayer SA (2016) Loss of consciousness at onset of subarachnoid hemorrhage as an important marker of early brain injury. JAMA Neurol 73:28–35
Svedung Wettervik T, Howells T, Lewén A, Ronne-Engström E, Enblad P (2021) Temporal dynamics of ICP, CPP, PRx, and CPPopt in high-grade aneurysmal subarachnoid hemorrhage and the relation to clinical outcome. Neurocrit Care 34:390–402
Svedung Wettervik T, Hånell A, Howells T, Ronne-Engström E, Lewén A, Enblad P (2022) Intracranial pressure- and cerebral perfusion pressure threshold-insults in relation to cerebral energy metabolism in aneurysmal subarachnoid hemorrhage. Acta Neurochir 164:1001–1014
Tack RW, Vergouwen MD, van der Schaaf I, van der Zwan A, Rinkel GJ, Lindgren AE (2019) Preventable poor outcome from rebleeding by emergency aneurysm occlusion in patients with aneurysmal subarachnoid haemorrhage. Eur Stroke J 4:240–246
Tervonen J, Adams H, Lindgren A, Elomaa AP, Kämäräinen OP, Kärkkäinen V, von Und Zu, Fraunberg M, Huttunen J, Koivisto T, Jääskeläinen JE, Leinonen V, Huuskonen TJ (2021) Shunt performance in 349 patients with hydrocephalus after aneurysmal subarachnoid hemorrhage. Acta Neurochir 163:2703–2714
Theyers AE, Zamyadi M, O’Reilly M, Bartha R, Symons S, MacQueen GM, Hassel S, Lerch JP, Anagnostou E, Lam RW, Frey BN, Milev R, Müller DJ, Kennedy SH, Scott CJM, Strother SC, Arnott SR (2021) Multisite comparison of MRI defacing software across multiple cohorts. Front Psychiatry. https://doi.org/10.3389/fpsyt.2021.617997
van der Steen WE, Marquering HA, Ramos LA, van den Berg R, Coert BA, Boers AMM, Vergouwen MDI, Rinkel GJE, Velthuis BK, Roos YBWEM, Majoie CBLM, Vandertop WP, Verbaan D (2020) Prediction of outcome using quantified blood volume in aneurysmal SAH. AJNR Am J Neuroradiol 41:1015–1021
van Veluw SJ, Arfanakis K, Schneider JA (2022) Neuropathology of vascular brain health: insights from ex vivo magnetic resonance imaging-histopathology studies in cerebral small vessel disease. Stroke 53:404–415
Veldeman M, Albanna W, Weiss M, Conzen C, Schmidt TP, Schulze-Steinen H, Wiesmann M, Clusmann H, Schubert GA (2020) Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage. J Neurosurg 134:1527–1534
Volovici V, Dammers R, Meling TR (2021) The “weekend effect” and outcomes after clipping of ruptured intracranial aneurysms-general healthcare metrics and trained vascular neurosurgeons. Acta Neurochir 163:793–795
von Holst H, Li X, Kleiven S (2012) Increased strain levels and water content in brain tissue after decompressive craniotomy. Acta Neurochir 154:1583–1593
Walter S, Audebert HJ, Katsanos AH, Larsen K, Sacco S, Steiner T, Turc G, Tsivgoulis G (2022) European Stroke Organisation (ESO) guidelines on mobile stroke units for prehospital stroke management. Eur Stroke J 7:27–59
Wan A, Jaja BN, Schweizer TA, Macdonald RL, on behalf of the SAHIT collaboration (2016) Clinical characteristics and outcome of aneurysmal subarachnoid hemorrhage with intracerebral hematoma. J Neurosurg 125:1344–1351
Wang MQ, Zhao X, Wang XF, Han C, Xing DG, Wang CW (2018) Surgical management of aneurysmal hematomas in the presence of brain herniation on arrival: a single-center case series analysis. World Neurosurg 114:468–476
Weiland J, Beez A, Westermaier T, Kunze E, Sirén AL, Lilla N (2021) Neuroprotective strategies in aneurysmal subarachnoid hemorrhage (aSAH). Int J Mol Sci. https://doi.org/10.3390/ijms22115442
White JD, Indencleef K, Naqvi S, Eller RJ, Hoskens H, Roosenboom J, Lee MK, Li J, Mohammed J, Richmond S, Quillen EE, Norton HL, Feingold E, Swigut T, Marazita ML, Peeters H, Hens G, Shaffer JR, Wysocka J, Walsh S, Weinberg SM, Shriver MD, Claes P (2021) Insights into the genetic architecture of the human face. Nat Genet 53:45–53
Wijdicks EFM (2022) Bringing the second event to light (on a light box): cerebral vasospasm after aneurysmal rupture. Neurocrit Care. https://doi.org/10.1007/s12028-022-01456-9
Wijdicks EFM (2018) On aneurysmal rupture and rerupture. Neurocrit Care 29:161–164
Wijdicks EFM (2022) 10 or 15 or 20 or 40 mmHg? What is increased intracranial pressure and who said so? Neurocrit Care 36:1022–1026
Wilent WB, Belyakina O, Korsgaard E, Tjoumakaris SI, Gooch MR, Jabbour P, Rosenwasser R, English JD, Kim W, Tesdahl E, Cohen J, Sestokas AK (2021) Intraoperative vascular complications during 2278 cerebral endovascular procedures with multimodality IONM: relationship between signal change, complication, intervention and postoperative outcome. J Neurointerv Surg 13:378–383
Yuan JY, Chen Y, Kumar A, Zlepper Z, Jayaraman K, Aung WY, Clarke JV, Allen M, Athiraman U, Osbun J, Zipfel GJ, Dhar R (2021) Automated quantification of reduced sulcal volume identifies early brain injury after aneurysmal subarachnoid hemorrhage. Stroke 52:1380–1389
Zhang Y, Liesz A, Li P (2021) Coming to the rescue: regulatory T cells for promoting recovery after ischemic stroke. Stroke 52:837–841
Zijlstra IA, van der Steen WE, Verbaan D, Majoie CB, Marquering HA, Coert BA, Vandertop WP, van den Berg R (2018) Ruptured middle cerebral artery aneurysms with a concomitant intraparenchymal hematoma: the role of hematoma volume. Neuroradiology 60:335–342
Acknowledgements
Research Nurse Katariina Helin for the data acquisition in the Kuopio Intracranial Aneurysm Patient & Family Database. Senior Expert Arto Poutala, M.Sc., for measuring the decompressive craniectomy bone flap areas (disior.com).
Funding
Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital. This study was funded by the Maire Taponen Foundation, Pro Humanitate Foundation, the Päivikki and Sakari Sohlberg Foundation, Kuopio University Hospital, and the Academy of Finland. The sponsors had no role in the design or conduction of this study.
Author information
Authors and Affiliations
Contributions
Name | Contribution | Affiliation |
---|---|---|
Anniina H. Autio, MD | Design and conceptualized study; acquisition of data; analyzed the data; drafted the manuscript for intellectual content | Kuopio University Hospital |
Juho Paavola, MD | Acquisition of data; revised the manuscript for intellectual content | Kuopio University Hospital |
Joona Tervonen, MD | Acquisition of data; revised the manuscript for intellectual content | Kuopio University Hospital |
Maarit Lång, MD | Acquisition of data; revised the manuscript for intellectual content | Kuopio University Hospital |
Terhi J. Huuskonen, MD, PhD | Revised the manuscript for intellectual content | Kuopio University Hospital |
Jukka Huttunen, MD, PhD | Revised the manuscript for intellectual content | Kuopio University Hospital |
Virve Kärkkäinen, PhD | Revised the manuscript for intellectual content | Kuopio University Hospital |
Mikael von Und Zu Fraunberg, MD, PhD | Revised the manuscript for intellectual content | Oulu University Hospital |
Antti E. Lindgren, MD, PhD | Revised the manuscript for intellectual content | Kuopio University Hospital |
Timo Koivisto MD, PhD | Revised the manuscript for intellectual content | Kuopio University Hospital |
Jouni Kurola, MD, PhD | Revised the manuscript for intellectual content | Kuopio University Hospital |
Juha E. Jääskeläinen, MD, PhD | Design and conceptualized study; acquisition of data; revised the manuscript for intellectual content; study supervision | Kuopio University Hospital |
Olli-Pekka Kämäräinen, MD, PhD | Design and conceptualized study; acquisition of data; revised the manuscript for intellectual content; study supervision | Kuopio University Hospital |
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Kuopio University Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Kuopio University Hospital.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comments
We would like to compliment the authors for their visionary take on data analysis and want to emphasize the value of this individualized timeline approach. First of all, this strategy of data presentation allows one to draw lines between multiple factors / events that may influence one another and result in the manifestation of complications such as delayed cerebral ischemia or edema. It also informs physicians about the relevance of the timing of interventions on different outcome parameters, which the authors justly refer to as "time is brain". As such, it enables us to go from a reductionist appraisal of data to a more holistic and comprehensive analysis of data that is available for internal as well as external interested parties. This may improve adequate comparisons between hospitals and stimulate best practice strategies. Lastly, this type of data presentation offers a great opportunity for personalized medicine whereby genotype-phenotype interactions may become more clear and results could improve our understanding of the pathomechanisms of various phenomena in disorders such as aneurysmal subarachnoid hemorrhages.
We envision healthcare systems that are geared towards optimal and efficient healthcare management. For such healthcare systems, obtaining and organizing systemic information from pre-hospital settings to post-hospital settings for all patients is a prerequisite. We are very well aware that this process is still very time-consuming, yet are convinced that technological advancements will allow data processing from electronic patient files systems to facilitate this process and ultimately improve the quality of care.
Hanna Schenck, Roel Haeren
Maastricht, the Netherlands
This article is part of the Topical Collection on Vascular Neurosurgery - Aneurysm
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Autio, A.H., Paavola, J., Tervonen, J. et al. Should individual timeline and serial CT/MRI panels of all patients be presented in acute brain insult cohorts? A pilot study of 45 patients with decompressive craniectomy after aneurysmal subarachnoid hemorrhage. Acta Neurochir 165, 3299–3323 (2023). https://doi.org/10.1007/s00701-022-05473-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-022-05473-7